Duncan Gregory Scott 4/A
4/A · Virios Therapeutics, Inc. · Filed Feb 15, 2023
Insider Transaction Report
Form 4/AAmended
Duncan Gregory Scott
DirectorCHIEF EXECUTIVE OFFICER
Transactions
- Award
Stock Option (right to buy)
2022-12-12+410,000→ 410,000 totalExercise: $0.28Exp: 2032-12-12→ Common Stock (410,000 underlying)
Footnotes (2)
- [F1]The reporting person filed a Form 4 on December 14, 2022 which incorrectly reported that on December 12, 2022 he was granted 480,000 Stock Options. This Form 4 amendment is being filed for the purpose of amending and restating the Form 4 to reflect that the reporting person was granted 410,000 Stock Options.
- [F2]The stock option vests one-third on December 12, 2023 and 1/24th monthly thereafter.